MedPath

Deltasone

Deltasone Tablets USP

Approved
Approval ID

d0acd7fb-8401-424f-9acc-a74dcd9b14f6

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 2, 2018

Manufacturers
FDA

Sonoma Pharmaceuticals, Inc.

DUNS: 081642964

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PredniSONE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69668-220
Application NumberANDA087342
Product Classification
M
Marketing Category
C73584
G
Generic Name
PredniSONE
Product Specifications
Route of AdministrationORAL
Effective DateNovember 2, 2018
FDA Product Classification

INGREDIENTS (6)

MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
SODIUM GLYCOLATEInactive
Code: B75E535IMI
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
PREDNISONEActive
Quantity: 20 mg in 1 1
Code: VB0R961HZT
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Deltasone - FDA Drug Approval Details